“Joining forces with Anthropic will supercharge our R&D organisation and help us on our mission to bring new, transformative health solutions to people living with chronic diseases,” said Mike Doustdar, president and chief executive of Novo. The Danish drugmaker, formerly branded Novo Nordisk, and Anthropic announced a collaboration on 16 September, according to Novo’s announcement. […]
This story continues at The Next Web